Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             152 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Advanced Drug Delivery Reviews: Advancing science, improving therapy Lee, Vincent H.L.
 2011
 1-2 p. 1-2
2 p.
 artikel
2 Affinity reagents against tumour-associated extracellular molecules and newforming vessels Neri, Dario
 1998
 1-2 p. 43-52
10 p.
 artikel
3 An antigenomic strategy for treating heteroplasmic mtDNA disorders Taylor, Robert W.
 2001
 1-2 p. 121-125
5 p.
 artikel
4 Anatomy, physiology and function of the nasal cavities in health and disease Mygind, Niels
 1998
 1-2 p. 3-12
10 p.
 artikel
5 An examination of the factors affecting intestinal lymphatic transport of dietary lipids Nordskog, Brian K.
 2001
 1-2 p. 21-44
24 p.
 artikel
6 Animal models for the study of intestinal lymphatic drug transport Edwards, Glenn A
 2001
 1-2 p. 45-60
16 p.
 artikel
7 Announcement 1990
 1-2 p. v-
1 p.
 artikel
8 Antibodies for targeted gene therapy: extracellular gene targeting and intracellular expression Dana Jones, Susan
 1998
 1-2 p. 153-170
18 p.
 artikel
9 Anticancer therapy using glucuronate modified long-circulating liposomes Oku, Naoto
 1999
 1-2 p. 63-73
11 p.
 artikel
10 Biodegradable hydrogels in drug delivery Kamath, Kalpana R.
 1993
 1-2 p. 59-84
26 p.
 artikel
11 Biomechanics of cell interactions in shear fields Konstantopoulos, Konstantinos
 1998
 1-2 p. 141-164
24 p.
 artikel
12 Biophysical kinetic modeling of buccal absorption Ho, N.F.H.
 1993
 1-2 p. 61-97
37 p.
 artikel
13 Bispecific antibodies for treatment of cancer in experimental animal models and man Kroesen, B.J
 1998
 1-2 p. 105-129
25 p.
 artikel
14 Buccal delivery systems using hydrogels Nagai, Tsuneji
 1993
 1-2 p. 179-191
13 p.
 artikel
15 Caco-2 monolayers in experimental and theoretical predictions of drug transport Artursson, Per
 1996
 1-2 p. 67-84
18 p.
 artikel
16 Carrier-mediated transport and efflux mechanisms in Caco-2 cells Hidalgo, Ismael J.
 1996
 1-2 p. 53-66
14 p.
 artikel
17 Cationic bolasomes with delocalized charge centers as mitochondria-specific DNA delivery systems Weissig, Volkmar
 2001
 1-2 p. 127-149
23 p.
 artikel
18 Cell-based tissue engineering therapies: the influence of whole body physiology. Haynesworth, Stephen E.
 1998
 1-2 p. 3-14
12 p.
 artikel
19 Cell delivery to the central nervous system Shoichet, Molly S
 2000
 1-2 p. 81-102
22 p.
 artikel
20 Cells for drug delivery platforms Han Bae, You
 2000
 1-2 p. 1-2
2 p.
 artikel
21 Cell transplantation for endocrine disorders Lee, Moon-Kyu
 2000
 1-2 p. 103-120
18 p.
 artikel
22 Cellular transplants as sources for therapeutic agents Tresco, Patrick A.
 2000
 1-2 p. 3-27
25 p.
 artikel
23 Challenges in inhaled product development and opportunities for open innovation Forbes, Ben
 2011
 1-2 p. 69-87
19 p.
 artikel
24 Chemical targeting of drug therapy in asthma and airways disease Seale, J.Paul
 1990
 1-2 p. 73-92
20 p.
 artikel
25 Chewing gum as a drug delivery system Rømer Rassing, Margrethe
 1994
 1-2 p. 89-121
33 p.
 artikel
26 Clearance properties of liposomes involving conjugated proteins for targeting Harasym, Troy O.
 1998
 1-2 p. 99-118
20 p.
 artikel
27 Controlling liposome blood clearance by surface-grafted polymers Woodle, Martin C
 1998
 1-2 p. 139-152
14 p.
 artikel
28 Creating and engineering human antibodies for immunotherapy de Haard, Hans
 1998
 1-2 p. 5-31
27 p.
 artikel
29 Culture of organized cell communities Freed, Lisa E
 1998
 1-2 p. 15-30
16 p.
 artikel
30 Delivery of antifungal agents to the oral cavity Samaranayake, Lakshman P.
 1994
 1-2 p. 161-179
19 p.
 artikel
31 Delivery systems for the administration of drugs to the periodontal pocket Medlicott, Natalie J.
 1994
 1-2 p. 181-203
23 p.
 artikel
32 Delocalized lipophilic cations selectively target the mitochondria of carcinoma cells Modica-Napolitano, Josephine S
 2001
 1-2 p. 63-70
8 p.
 artikel
33 Determinants of drug and polypeptide bioavailability from aerosols delivered to the lung Byron, Peter R.
 1990
 1-2 p. 107-132
26 p.
 artikel
34 Development of engineered cells for implantation in gene therapy Chang, Patricia L.
 1998
 1-2 p. 31-43
13 p.
 artikel
35 Development of engineered pancreatic β-cell lines for cell therapy of diabetes Efrat, Shimon
 1998
 1-2 p. 45-52
8 p.
 artikel
36 Development of intestinal cell culture models for drug transport and metabolism studies Quaroni, A.
 1996
 1-2 p. 3-52
50 p.
 artikel
37 Drug and DNA delivery to mitochondria 2001
 1-2 p. 1-2
2 p.
 artikel
38 Drug delivery strategies in malignant disease of the lung Willmott, N.
 1990
 1-2 p. 133-148
16 p.
 artikel
39 Drug metabolism in the oral cavity Yamahara, Hiroshi
 1993
 1-2 p. 25-39
15 p.
 artikel
40 Editorial 1998
 1-2 p. 1-
1 p.
 artikel
41 Editorial 1998
 1-2 p. 1-2
2 p.
 artikel
42 Editorial Board 1996
 1-2 p. ii-
1 p.
 artikel
43 Editorial Board 1993
 1-2 p. ii-
1 p.
 artikel
44 Editorial Board 1994
 1-2 p. ii-
1 p.
 artikel
45 Editorial Board 2011
 1-2 p. ii-
1 p.
 artikel
46 Editorial Board 1993
 1-2 p. ii-
1 p.
 artikel
47 Editorial Board 1990
 1-2 p. ii-
1 p.
 artikel
48 Effects of physicochemical properties and other factors on systemic nasal drug delivery Behl, C.R
 1998
 1-2 p. 89-116
28 p.
 artikel
49 Endothelial cell delivery for cardiovascular therapy Parikh, Sahil A
 2000
 1-2 p. 139-161
23 p.
 artikel
50 Exploiting M cells for drug and vaccine delivery Clark, M.Ann
 2001
 1-2 p. 81-106
26 p.
 artikel
51 Formulation of oral mucosal drug delivery systems for the systemic delivery of bioactive materials Ponchel, Gilles
 1994
 1-2 p. 75-87
13 p.
 artikel
52 Forthcoming articles 1994
 1-2 p. 205-206
2 p.
 artikel
53 Forthcoming articles 1993
 1-2 p. 193-195
3 p.
 artikel
54 Forthcoming articles 1993
 1-2 p. 127-128
2 p.
 artikel
55 Forthcoming events 1993
 1-2 p. 129-130
2 p.
 artikel
56 Forthcoming events 1994
 1-2 p. 207-208
2 p.
 artikel
57 Forthcoming events 1993
 1-2 p. 197-199
3 p.
 artikel
58 Gene therapy approaches for modulating bone regeneration Winn, Shelley R
 2000
 1-2 p. 121-138
18 p.
 artikel
59 Gene therapy by mitochondrial transfer Kagawa, Yasuo
 2001
 1-2 p. 107-119
13 p.
 artikel
60 Gene therapy for tissue repair and regeneration Bonadio, Jeffrey
 1998
 1-2 p. 53-69
17 p.
 artikel
61 Host response to tissue engineered devices Babensee, Julia E.
 1998
 1-2 p. 111-139
29 p.
 artikel
62 Human mitochondrial DNA diseases Pulkes, T
 2001
 1-2 p. 27-43
17 p.
 artikel
63 Hydrogel delivery systems based on polymer blends, block co-polymers or interpenetrating networks Bae, You Han
 1993
 1-2 p. 109-135
27 p.
 artikel
64 Hydrogel delivery systems for vaginal and oral applications Knuth, Kim
 1993
 1-2 p. 137-167
31 p.
 artikel
65 Identification of proteins mediating clearance of liposomes using a liver perfusion system Harashima, H
 1998
 1-2 p. 61-79
19 p.
 artikel
66 Immunocompatibility and biocompatibility of cell delivery systems Řı́hová, Blanka
 2000
 1-2 p. 65-80
16 p.
 artikel
67 Immunoliposomes for the targeted delivery of antitumor drugs Mastrobattista, Enrico
 1999
 1-2 p. 103-127
25 p.
 artikel
68 Immunotoxins for targeted cancer therapy Kreitman, Robert J
 1998
 1-2 p. 53-88
36 p.
 artikel
69 Interactions of liposomes and lipid-based carrier systems with blood proteins: Relation to clearance behaviour in vivo Semple, Sean C
 1998
 1-2 p. 3-17
15 p.
 artikel
70 Intestinal lymphatic drug transport: an update Porter, Christopher J.H.
 2001
 1-2 p. 61-80
20 p.
 artikel
71 Intranasal drug delivery Hussain, Anwar A
 1998
 1-2 p. 39-49
11 p.
 artikel
72 Intravital microscopy as a tool to study drug delivery in preclinical studies Amornphimoltham, Panomwat
 2011
 1-2 p. 119-128
10 p.
 artikel
73 In vitro cell models to study nasal mucosal permeability and metabolism Schmidt, M.Christiane
 1998
 1-2 p. 51-79
29 p.
 artikel
74 Large molecule and particulate uptake in the nasal cavity: the effect of size on nasal absorption Donovan, Maureen D
 1998
 1-2 p. 147-155
9 p.
 artikel
75 Liposomes as drug delivery systems to the lung Kellaway, Ian W.
 1990
 1-2 p. 149-161
13 p.
 artikel
76 Liposomes to target the lymphatics by subcutaneous administration Oussoren, Christien
 2001
 1-2 p. 143-156
14 p.
 artikel
77 Local delivery of antimicrobial agents to the oral cavity Addy, Martin
 1994
 1-2 p. 123-134
12 p.
 artikel
78 Lymphatic transport of proteins after s.c. injection: implications of animal model selection Porter, C.J.H
 2001
 1-2 p. 157-171
15 p.
 artikel
79 Man-made superantigens: Tumor-selective agents for T-cell-based therapy Brodin, Thomas N
 1998
 1-2 p. 131-142
12 p.
 artikel
80 Materials for immunoisolated cell transplantation Li, Rebecca H
 1998
 1-2 p. 87-109
23 p.
 artikel
81 Materials for protein delivery in tissue engineering Baldwin, Samuel P
 1998
 1-2 p. 71-86
16 p.
 artikel
82 Mathematical modeling of deposition and disposition of drugs administered via the nose Gonda, Igor
 1998
 1-2 p. 179-184
6 p.
 artikel
83 Mechanisms and kinetics of liposome–cell interactions Düzgüneş, Nejat
 1999
 1-2 p. 3-18
16 p.
 artikel
84 Mechanisms, barriers and pathways of oral mucosal drug permeation Rathbone, Michael J.
 1993
 1-2 p. 41-60
20 p.
 artikel
85 Methods for assessing the buccal mucosa as a route of drug delivery Janet Hoogstraate, A.
 1993
 1-2 p. 99-125
27 p.
 artikel
86 Microspheres as nasal drug delivery systems Pereswetoff-Morath, Lena
 1998
 1-2 p. 185-194
10 p.
 artikel
87 Mitochondria as subcellular targets for clinically useful anthracyclines Jung, Katinka
 2001
 1-2 p. 87-105
19 p.
 artikel
88 Mitochondria as target for antiischemic drugs Morin, Didier
 2001
 1-2 p. 151-174
24 p.
 artikel
89 Mitochondria-based photodynamic anti-cancer therapy Morgan, Janet
 2001
 1-2 p. 71-86
16 p.
 artikel
90 Mitochondrial contributions to cancer cell physiology: potential for drug development Preston, Thomas J
 2001
 1-2 p. 45-61
17 p.
 artikel
91 Mitochondrial DNA metabolism targeting drugs Rowe, Thomas C
 2001
 1-2 p. 175-187
13 p.
 artikel
92 Mitochondria make a come back Scheffler, Immo E.
 2001
 1-2 p. 3-26
24 p.
 artikel
93 Mucus and mucociliary clearance in the respiratory tract Marriott, C.
 1990
 1-2 p. 19-35
17 p.
 artikel
94 Nasal delivery systems and their effect on deposition and absorption Kublik, H
 1998
 1-2 p. 157-177
21 p.
 artikel
95 Nasal mucociliary clearance as a factor in nasal drug delivery Marttin, Emmeline
 1998
 1-2 p. 13-38
26 p.
 artikel
96 Novel vaginal drug release applications Brannon-Peppas, Lisa
 1993
 1-2 p. 169-177
9 p.
 artikel
97 Optimization of systemic nasal drug delivery with pharmaceutical excipients Behl, C.R
 1998
 1-2 p. 117-133
17 p.
 artikel
98 Oral cavity as a site for bioadhesive drug delivery Gandhi, Rajesh B.
 1994
 1-2 p. 43-74
32 p.
 artikel
99 Overview of clinical trials employing antibody-targeted superantigens Alpaugh, R.Katherine
 1998
 1-2 p. 143-152
10 p.
 artikel
100 Peptide hormones: Review of current and emerging uses by nasal delivery Pontiroli, Antonio E
 1998
 1-2 p. 81-87
7 p.
 artikel
101 Permeability and the pathophysiology of oral mucosa Squier, Christopher A.
 1993
 1-2 p. 13-24
12 p.
 artikel
102 Pharmacokinetic/pharmacodynamic modeling of antitumor agents encapsulated into liposomes Harashima, H.
 1999
 1-2 p. 39-61
23 p.
 artikel
103 Pharmacokinetics of anticancer drugs, plasmid DNA, and their delivery systems in tissue-isolated perfused tumors Nishikawa, Makiya
 1999
 1-2 p. 19-37
19 p.
 artikel
104 Possibility of active targeting to tumor tissues with liposomes Maruyama, Kazuo
 1999
 1-2 p. 89-102
14 p.
 artikel
105 Preface Dohlsten, Mikael
 1998
 1-2 p. 1-3
3 p.
 artikel
106 Preface Hochman, Jerome H.
 1996
 1-2 p. 1-
1 p.
 artikel
107 Preface Rathbone, M.J.
 1993
 1-2 p. vii-viii
nvt p.
 artikel
108 Preface Scranton, Alec B.
 1993
 1-2 p. vii-viii
nvt p.
 artikel
109 Preface Rathbone, M.J.
 1994
 1-2 p. v-vi
nvt p.
 artikel
110 Preface Mitra, Ashim K
 1998
 1-2 p. 1-
1 p.
 artikel
111 Preface. Major issues and future prospects in the delivery of therapeutic and diagnostic agents to the respiratory tract Gonda, Igor
 1990
 1-2 p. 1-9
9 p.
 artikel
112 Preparation, structure and diffusional behavior of hydrogels in controlled release Peppas, Nikolaos A.
 1993
 1-2 p. 1-35
35 p.
 artikel
113 Problems and opportunities in the topical treatment of infectious diseases of the respiratory tract Ilowite, Jonathan S.
 1990
 1-2 p. 93-105
13 p.
 artikel
114 Prodrug-based intracellular delivery of anticancer agents Bildstein, L.
 2011
 1-2 p. 3-23
21 p.
 artikel
115 Prodrugs for nasal drug delivery Krishnamoorthy, Ramesh
 1998
 1-2 p. 135-146
12 p.
 artikel
116 Production and selection of antigen-specific fully human monoclonal antibodies from mice engineered with human Ig loci Jakobovits, Aya
 1998
 1-2 p. 33-42
10 p.
 artikel
117 Pulsatile drug delivery systems using hydrogels Yoshida, Ryo
 1993
 1-2 p. 85-108
24 p.
 artikel
118 Recent advances in the understanding of uptake of microparticulates across the gastrointestinal lymphatics Hussain, Nasir
 2001
 1-2 p. 107-142
36 p.
 artikel
119 Receptor versus non-receptor mediated clearance of liposomes Scherphof, Gerrit L
 1998
 1-2 p. 81-97
17 p.
 artikel
120 Recombinant DNA technology as an investigative tool in drug metabolism research Friedberg, Thomas
 1996
 1-2 p. 187-213
27 p.
 artikel
121 Reconstitution of the blood-brain barrier in cell culture for studies of drug transport and metabolism de Boer, A.G.
 1996
 1-2 p. 251-264
14 p.
 artikel
122 Regional variation in the structure and permeability of oral mucosa and skin Wertz, Philip W.
 1993
 1-2 p. 1-12
12 p.
 artikel
123 Respiratory epithelial cell culture models for evaluation of ion and drug transport Mathias, Neil R.
 1996
 1-2 p. 215-249
35 p.
 artikel
124 RNA delivery into mitochondria Entelis, N.S
 2001
 1-2 p. 199-215
17 p.
 artikel
125 RNA interference for improving the outcome of islet transplantation Li, Feng
 2011
 1-2 p. 47-68
22 p.
 artikel
126 Saliva substitutes in the management of salivary gland dysfunction Ferguson, M.M.
 1994
 1-2 p. 151-159
9 p.
 artikel
127 Serum-mediated recognition of liposomes by phagocytic cells of the reticuloendothelial system – The concept of tissue specificity Moghimi, S.M
 1998
 1-2 p. 45-60
16 p.
 artikel
128 Site-specific differences in the salivary concentrations of substances in the oral cavity — implications for the aetiology of oral disease and local drug delivery Weatherell, John A.
 1994
 1-2 p. 23-42
20 p.
 artikel
129 Spatial expression and functionality of drug transporters in the intact lung: Objectives for further research Gumbleton, Mark
 2011
 1-2 p. 110-118
9 p.
 artikel
130 Strategies for restoration and maintenance of normal hepatic structure and function in long-term cultures of rat hepatocytes LeCluyse, Edward L.
 1996
 1-2 p. 133-186
54 p.
 artikel
131 Structural and metabolic consequences of liposome–lipoprotein interactions Rodrigueza, Wendi V
 1998
 1-2 p. 31-43
13 p.
 artikel
132 Superparamagnetic iron oxide nanoparticles (SPIONs): Development, surface modification and applications in chemotherapy Mahmoudi, Morteza
 2011
 1-2 p. 24-46
23 p.
 artikel
133 Swelling-controlled release in hydrogel matrices for oral route Colombo, Paolo
 1993
 1-2 p. 37-57
21 p.
 artikel
134 Targeted delivery of chemotherapeutics: tumor-activated prodrug therapy Chari, Ravi V.J
 1998
 1-2 p. 89-104
16 p.
 artikel
135 Targeting large molecules to mitochondria Muratovska, Aleksandra
 2001
 1-2 p. 189-198
10 p.
 artikel
136 Technology of mammalian cell encapsulation Uludag, Hasan
 2000
 1-2 p. 29-64
36 p.
 artikel
137 The absorption and metabolism of xenobiotics in the lung Taylor, Glyn
 1990
 1-2 p. 37-61
25 p.
 artikel
138 The circulation of the airways: anatomy, physiology and potential role in drug delivery to the respiratory tract Chediak, Alejandro D.
 1990
 1-2 p. 11-18
8 p.
 artikel
139 The complement system in liposome clearance: Can complement deposition be inhibited? Devine, Dana V
 1998
 1-2 p. 19-29
11 p.
 artikel
140 The handling of inhaled antigen within the respiratory tract Clancy, Robert L.
 1990
 1-2 p. 63-72
10 p.
 artikel
141 The oral cavity as a site for systemic drug delivery Rathbone, Michael J.
 1994
 1-2 p. 1-22
22 p.
 artikel
142 Theoretical considerations of RES-avoiding liposomes: Molecular mechanics and chemistry of liposome interactions Papisov, Mikhail I
 1998
 1-2 p. 119-138
20 p.
 artikel
143 The Pharmacokinetics of Liposomes in Tumor Targeting Harashima, Hideyoshi
 1999
 1-2 p. 1-2
2 p.
 artikel
144 The physiology of the lymphatic system Swartz, Melody A.
 2001
 1-2 p. 3-20
18 p.
 artikel
145 The size of liposomes: a factor which affects their targeting efficiency to tumors and therapeutic activity of liposomal antitumor drugs Nagayasu, A
 1999
 1-2 p. 75-87
13 p.
 artikel
146 The use of adult human hepatocytes in primary culture and other in vitro systems to investigate drug metabolism in man Maurel, Patrick
 1996
 1-2 p. 105-132
28 p.
 artikel
147 The use of the intestinal epithelial cell culture model, Caco-2, in pharmaceutical development Bailey, Carole A.
 1996
 1-2 p. 85-103
19 p.
 artikel
148 Topical corticosteroids and lesions of the oral mucosa Thorburn, Dennis N.
 1994
 1-2 p. 135-149
15 p.
 artikel
149 Toward managing chronic rejection after lung transplant: The fate and effects of inhaled cyclosporine in a complex environment Niven, Ralph W.
 2011
 1-2 p. 88-109
22 p.
 artikel
150 Transplantation of cells in matrices for tissue regeneration Marler, Jennifer J
 1998
 1-2 p. 165-182
18 p.
 artikel
151 Transport and absorption of drugs via the lymphatic system 2001
 1-2 p. 1-2
2 p.
 artikel
152 Tyrosine kinase chimeras for antigen-selective T-body therapy Fitzer-Attas, Cheryl J
 1998
 1-2 p. 171-182
12 p.
 artikel
                             152 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland